Leukemia, Adult T-Cell
2 clinical trials · Condition
◉ Watch Leukemia, Adult T-Cell
| Record | Firm | Date |
|---|---|---|
| Ruxolitinib for Adult T-Cell Leukemia (NCT01712659) | National Cancer Institute (NCI) | 2012-10-26 |
| Phase II Study of the Efficacy and Toxicity of Ontak(Registered Trademark) (Denileukin Diftitox) in the Therapy of Adult T-Cell Leukemia (NCT00117845) | National Cancer Institute (NCI) | 2005-07-11 |
Track Leukemia, Adult T-Cell automatically
Every clearance here is in the API, with alerts when new ones post.